National Institutes of Health to Grant Exclusive License for Cancer Treatment Method

Summary

The National Institutes of Health is considering granting an exclusive worldwide license to Medicenna Therapeutics, Inc. for a method of delivering a therapeutic agent to treat cancer and urological diseases, using a convection enhanced delivery system with a surrogate tracer.